Cold Sore Medication Manufacturing in the US - Industry Market Research Report
Description
Cold Sore Medication Manufacturing
Over the five years to 2019, revenue for the Cold Sore Medication Manufacturing industry grew. Generally speaking, demand for cold sore medication is driven by broader trends such as changes in disposable income, demographic shifts and total healthcare expenditure. Changes in private health insurance coverage can also cause demand to rise or fall, as a portion of industry products include pharmaceutical treatments to treat conditions that arise from herpes simplex virus or herpes zoster virus. Still, manufacturers are expected to contend with rising competition over the next five years to 2024 from generic offerings and OTC products, which carry lower profit margins. Generics are often sold at a discounted rate as compared with brand name offerings and have been increasingly prescribed to reduce rising healthcare costs in the United States.
This industry develops and produces over-the-counter (OTC) and prescription treatments for cold sores, which are inflamed blisters in or near the mouth caused by infection from the herpes simplex virus.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Over the five years to 2019, revenue for the Cold Sore Medication Manufacturing industry grew. Generally speaking, demand for cold sore medication is driven by broader trends such as changes in disposable income, demographic shifts and total healthcare expenditure. Changes in private health insurance coverage can also cause demand to rise or fall, as a portion of industry products include pharmaceutical treatments to treat conditions that arise from herpes simplex virus or herpes zoster virus. Still, manufacturers are expected to contend with rising competition over the next five years to 2024 from generic offerings and OTC products, which carry lower profit margins. Generics are often sold at a discounted rate as compared with brand name offerings and have been increasingly prescribed to reduce rising healthcare costs in the United States.
This industry develops and produces over-the-counter (OTC) and prescription treatments for cold sores, which are inflamed blisters in or near the mouth caused by infection from the herpes simplex virus.
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
39 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
